MENU
NAMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NewAmsterdam Pharma (NAMS) Earnings Date & Reports

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated... Show more

A.I. Advisor
published Earnings

NAMS is expected to report earnings to fall 46.59% to -49 cents per share on May 07

NewAmsterdam Pharma NAMS Stock Earnings Reports
Q1'25
Est.
$-0.50
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.32
Q2'24
Beat
by $0.17
Q1'24
Missed
by $0.44
The last earnings report on February 26 showed earnings per share of -93 cents, beating the estimate of -95 cents. With 1.43M shares outstanding, the current market capitalization sits at 2.00B.
View a ticker or compare two or three
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com